Use your antibodies-online credentials, if available.
Il n’y a pas de produits dans votre liste de comparaison.
Votre panier est vide.
Afficher tous les synonymes
Human Monoclonal CCL19 Primary Antibody pour FACS, ICC - ABIN4899709
Berrih-Aknin, Ruhlmann, Bismuth, Cizeron-Clairac, Zelman, Shachar, Dartevelle, de Rosbo, Le Panse: CCL21 overexpressed on lymphatic vessels drives thymic hyperplasia in myasthenia. dans Annals of neurology 2009
Show all 4 Pubmed References
Human Polyclonal CCL19 Primary Antibody pour IF (p), IHC (p) - ABIN740505
Borrelli, Abrão, Taube, Darb-Esfahani, Köhler, Kaufmann, Chiantera, Mechsner: Immunohistochemical Investigation of Metastasis-Related Chemokines in Deep-Infiltrating Endometriosis and Compromised Pelvic Sentinel Lymph Nodes. dans Reproductive sciences (Thousand Oaks, Calif.) 2015
these data indicate CCL19/CCR7 (Montrer CCR7 Anticorps) contributes to proliferation and invasion of ESCs (Montrer NR2E3 Anticorps), which are conducive to the pathogenesis of endometriosis through activating PI3K (Montrer PIK3CA Anticorps)/Akt (Montrer AKT1 Anticorps) pathway
The research findings demonstrate for the first time that the chemokines CCL19, CCL21 (Montrer CCL21 Anticorps) and CCR7 (Montrer CCR7 Anticorps) play important roles in bone destruction by increasing osteoclast migration and resorption activity, and that has been linked to rheumatoid arthritis pathogenesis.
breast cancers-derived soluble factors increase the migration of DCs toward CCL19.
The migratory index to the CCR7 (Montrer CCR7 Anticorps) ligands, CCL19 and CCL21 (Montrer CCL21 Anticorps), was higher in T-cells from donors whose recipients will develop GvHD.
Study confirmes that CCL19 induces the invasion and migration of breast cancer cells through the expression of markers of epithelial-mesenchymal transition.
findings connect NOTCH1 (Montrer NOTCH1 Anticorps), DUSP22 (Montrer DUSP22 Anticorps), and CCL19-driven chemotaxis within a single functional network, suggesting that modulation of the homing process may provide a relevant contribution to the unfavorable prognosis associated with NOTCH1 (Montrer NOTCH1 Anticorps) mutations in CLL.
Deletion of this extended C-terminus reduces CCL21 (Montrer CCL21 Anticorps)'s affinity for heparin and transferring the CCL21 (Montrer CCL21 Anticorps) C-terminus to CCL19 enhances heparin binding mainly through non-specific, electrostatic interactions
CCL19 is significantly overexpressed in patients with unstable carotid atherosclerotic plaques and may be a possible novel biomarker for identifying high-risk patients in whom more urgent intervention may be indicated.
CrkL (Montrer CRKL Anticorps) regulates CCL19 and CCR7 (Montrer CCR7 Anticorps)-induced epithelial-to-mesenchymal transition via ERK (Montrer EPHB2 Anticorps) signaling pathway in epithelial ovarian carcinoma patients.
observed significantly higher concentrations of IL-8 (Montrer IL8 Anticorps) (p < 0.001), MCP-1 (Montrer CCL2 Anticorps) (p = 0.014), and MIP (Montrer TNPO1 Anticorps)-3beta (p = 0.022) in the PF of women with endometriosis than in the controls.
These data show that CCR7 (Montrer CCR7 Anticorps)-CCL19/CCL21 (Montrer CCL21 Anticorps) axis facilitates retention CD4 (Montrer CD4 Anticorps)(+) T lymphocytes at the site of collateral artery remodeling, which is essential for effective arteriogenesis.
the white pulp regions of ME7-infected spleens were smaller, and contained markedly diminished T zones, as compared to control spleens. Although lymphoid tissue inducer cells were not affected, the expression of both CCL19 and CCL21 (Montrer CCL21 Anticorps) was decreased.
a comprehensive model of CCL19 and CCL21 (Montrer CCL21 Anticorps) transport and gradient formation in the lymph nodes (LNs) was built; predicts that ACKR4 in LNs prevents CCL19/CCL21 (Montrer CCL21 Anticorps) accumulation in efferent lymph, but does not control intranodal gradients; instead, it attributes the disrupted interfollicular CCL21 (Montrer CCL21 Anticorps) gradients observed in Ackr4-deficient LNs to ACKR4 loss upstream
The beneficial effects of epicatechin in ameriorating diet-induced obesity and insulin (Montrer INS Anticorps) resistance could be mediated, at least in part, by marked suppression of CCL19 expression.
Results suggest that baicalin exerts an inhibitory effect on airway inflammation, and this effect may be associated with the inhibition of CCR7 (Montrer CCR7 Anticorps) and its ligands, CCL19 and CCL21 (Montrer CCL21 Anticorps), as well as on the nuclear factor-Kappa B (NF-kappaB (Montrer NFKB1 Anticorps)) pathway in a mouse model of asthma.
Interferon-gamma (IFN-gamma (Montrer IFNG Anticorps)) and interleukin-12 (IL-12 (Montrer IL12A Anticorps)) levels in the tumors and plasma were significantly enhanced after processing with recombinant mouse CCL19.
Modulation of the chemokines CCL19 and CCL21 (Montrer CCL21 Anticorps) represents a potent immunoregulatory treatment approach, and thus represents a novel therapeutic target to stabilize atherosclerotic lesions.
CCL19 (ELC) improves TH1 (Montrer HAND1 Anticorps)-polarized immune responses and protective immunity in a murine Her2/neu (Montrer ERBB2 Anticorps) DNA vaccination model.
study shows that CCL19/21 and its possible signaling through CXCR3 (Montrer CXCR3 Anticorps) are required for the development of thymic metallophilic macrophages
This gene is one of several CC cytokine genes clustered on the p-arm of chromosome 9. Cytokines are a family of secreted proteins involved in immunoregulatory and inflammatory processes. The CC cytokines are proteins characterized by two adjacent cysteines. The cytokine encoded by this gene may play a role in normal lymphocyte recirculation and homing. It also plays an important role in trafficking of T cells in thymus, and in T cell and B cell migration to secondary lymphoid organs. It specifically binds to chemokine receptor CCR7.
C-C motif chemokine 19
, CC chemokine ligand 19
, CK beta-11
, EBI1 ligand chemokine
, EBI1-ligand chemokine
, beta chemokine exodus-3
, beta-chemokine exodus-3
, epstein-Barr virus-induced molecule 1 ligand chemokine
, macrophage inflammatory protein 3 beta
, macrophage inflammatory protein 3-beta
, small inducible cytokine subfamily A (Cys-Cys), member 19
, small-inducible cytokine A19
, chemokine (C-C motif) ligand 19
, CCL19 chemokine
, small inducible cytokine A19
, chemokine CCL19/MIP-3BETA
, EBI-1 ligand chemokine
, EBV-induced molecule 1 ligand chemokine
, chemokine CCL19